BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 16759456)

  • 1. [Evaluation of the effect of fertility-saving surgery on young patients with malignant ovarian tumors].
    Xi MR; Hou MM; Cao ZY; Zhang CS; Peng ZL; Wang HJ; Zheng A
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):233-6. PubMed ID: 16759456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy.
    Yoo SC; Kim WY; Yoon JH; Chang SJ; Chang KH; Ryu HS
    Acta Obstet Gynecol Scand; 2010; 89(1):126-30. PubMed ID: 19878051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
    Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
    Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the management of ovarian germ cell tumors.
    Lu KH; Gershenson DM
    J Reprod Med; 2005 Jun; 50(6):417-25. PubMed ID: 16050566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of fertility preserving operations in malignant ovarian tumors].
    Kleine W
    Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of early ovarian cancer: germ cell and sex cord-stromal tumors.
    Gershenson DM
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S62-72. PubMed ID: 7530680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery].
    Schröder W
    Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
    Weinberg LE; Lurain JR; Singh DK; Schink JC
    Gynecol Oncol; 2011 May; 121(2):285-9. PubMed ID: 21256579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-based chemotherapy in the management of germ cell tumors of the ovary: The Institut Gustave Roussy Experience.
    Culine S; Lhomme C; Kattan J; Michel G; Duvillard P; Droz JP
    Gynecol Oncol; 1997 Jan; 64(1):160-5. PubMed ID: 8995567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas.
    Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A
    Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
    Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of combined therapy for malignant ovarian tumors in girls].
    Kochurova NV; Urmancheeva AF; Kolygin BA
    Vopr Onkol; 2003; 49(4):492-5. PubMed ID: 14569944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer.
    Borgfeldt C; Iosif C; Måsbäck A
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):110-4. PubMed ID: 16859821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors.
    Zanagnolo V; Sartori E; Trussardi E; Pasinetti B; Maggino T
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):235-43. PubMed ID: 15921842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.